
DEM Bio is pioneering the next generation of immunotherapeutics that unleash macrophages and immune phagocytes to eliminate tumors by targeting 'Don't eat me' (DEM) and 'Eat me' (EM) signals on cancer cells and macrophages.
Create a free account to see full funding history, valuations, and investor participation.
Create Free AccountCreate a free account to see which investors have funded this company.